semaglutide recall Health Canada recalls lot of Ozempic Compounded Semaglutide Manufacturing Ban

In the Lira Pump study, they decreased basal insulin by 10%, but increased bolus by 15% ( Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes

This personalized approach remains valuable even after generics launch, because genetic insights guide dose optimization and compound selection

A co-worker received a text which is, unfortunately, becoming more common

How long does it take to see weight loss results with tirzepatide

Clear separation of migration, viability, survival, and proliferation endpoints improves the scientific usefulness of BPC-157 research interpretation